Protection of the ischemic diabetic heart by L-propionylcarnitine therapy
Authors:
- 1 October 1992
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 116 (1-2) , 131-137
Abstract
Diabetics suffer from an increased incidence of myocardial infarction and are less likely to survive an ischemic insult. Since L-propionylcarnitine (LPC) has been shown to protect against ischemic/reperfusion injury, we hypothesized that LPC may be of even greater benefit to the diabetic heart. Diabetes was induced by i.v. streptozotocin, 60 mg/kg; duration: 12 wks. The chronic effect of LPC was determined by daily i.p. injections (100 mg/kg) for 8 wks. The acute effects of LPC were determined by adding it to the perfusion medium (5 mM) of control and diabetic hearts. Initial cardiac contractile performance of isolated perfused working hearts was assessed by varying left atrial filling pressure. Hearts were then subjected to 90 min of low flow global ischemia followed by 30 min reperfusion. Chronic LPC treatment had no effect on initial cardiac performance in either control or diabetic hearts. Acute addition of LPC to the perfusion medium enhanced pump performance of control hearts, but had no effect in diabetic hearts. Both acute and chronic LPC significantly improved the ability of control and diabetic hearts to recover cardiac contractile performance after ischemia and reperfusion, however, chronic treatment was more effective in diabetic hearts.Keywords
This publication has 34 references indexed in Scilit:
- Electrophysiologic evaluation of intravenous L-propionylcarnitine in manInternational Journal of Cardiology, 1991
- Intracellular pH and role of Na+/H+ exchange during ischaemia and reperfusion of normal and diabetic rat heartsCardiovascular Research, 1990
- Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Diabetes mellitus and hypertension in the elderly: Concomitant hyperlipidemia and coronary heart disease riskThe American Journal of Cardiology, 1989
- Effects ofl-propionylcarnitine on electrical and mechanical alterations induced by amphiphilic lipids in isolated guinea pig ventricular muscleHeart and Vessels, 1988
- Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism.Circulation Research, 1988
- Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidationCardiovascular Research, 1986
- Improvement of myocardial function in diabetic rats after treatment with L-carnitineMetabolism, 1984
- Diabetes and the survival and recovery of the anoxic myocardiumJournal of Molecular and Cellular Cardiology, 1975
- Transfer Factor—a New Form for ImmunotherapyActa Medica Scandinavica, 1975